Öz
Maple syrup urine disease (MSUD) is an inborn error of metabolism characterized by an increase in branched-chain amino acids (BCAAs), resulting from a deficiency in the branched-chain α-ketoacid dehydrogenase (BCKD) enzyme. A 22-day-old asymptomatic male infant was referred to our center following the detection of elevated phenylalanine (PHE) levels in the newborn screening program and was hospitalized with suspected Phenylketonuria (PKU). Blood amino acid analysis revealed a normal PHE level (48.9 nmol/mL), while BCAA levels were markedly elevated: Leucine 824.4 nmol/mL (normal: 48-175), isoleucine 413.1 nmol/mL (normal: 31-105), and valine 683.1 nmol/mL (normal: 83-300). Results confirmed false positive result for PKU diagnosis however, laboratory findings were consistent with MSUD. Phenylketonuria, a preliminary diagnosis made due to high PHE levels in newborn screening, has masked the underlying MSUD diagnosis, and is presented here as an extremely rare phenomenon. This case is reported to underscore a critical gap in our country’s newborn screening program, which does not currently include MSUD. Considering the acute and potentially fatal neonatal presentation of MSUD, our findings underline the need to expand the national newborn screening program to include MSUD.
Anahtar Kelimeler: Branched-chain amino acids, leucine, maple syrup urine disease, phenylalanine, phenylketonuria
Kaynakça
- Chuang JL, Wynn RM, Moss CC, et al. Structural and biochemical basis for novel mutations in homozygous Israeli maple syrup urine disease patients: a proposed mechanism for the thiamin-responsive phenotype. J Biol Chem. 2004;279(17):17792-800. https://doi.org/10.1074/jbc.M313879200
- Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab. 2014;112(3):210-7. https://doi.org/10.1016/j.ymgme.2014.05.006
- Strauss KA, Carson VJ, Soltys K, et al. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. Mol Genet Metab. 2020;129(3):193-206. https://doi.org/10.1016/j.ymgme.2020.01.006
- Schadewaldt P, Wendel U. Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr. 1997;156 Suppl 1:S62-S66. https://doi.org/10.1007/PL00014274
- Hassan SA, Gupta V. Maple Syrup Urine Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 5, 2022.
- Stroek K, Boelen A, Bouva MJ, et al. Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization. JIMD Rep. 2020;54(1):68-78. Published 2020 May 13. https://doi.org/10.1002/jmd2.12124
- van Spronsen FJ, van Wegberg AM, Ahring K, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743-56. https://doi.org/10.1016/S2213-8587(16)30320-5
- Strauss KA, Puffenberger EG, Carson VJ. Maple Syrup Urine Disease. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; January 30, 2006.
- Duan Y, Li F, Li Y, et al. The role of leucine and its metabolites in protein and energy metabolism. Amino Acids. 2016;48(1):41-51. https://doi.org/10.1007/s00726-015-2067-1
- Capistrano-Estrada, Sylvia, and Charity M. Jomento. “Detection of maple syrup urine disease on newborn screening second tier testing for phenylketonuria.” Acta Medica Philippina 43.2 (2009). https://doi.org/10.47895/amp.v43i2.2509
- Manoli I, Venditti CP. Disorders of branched chain amino acid metabolism. Transl Sci Rare Dis. 2016;1(2):91-110. https://doi.org/10.3233/TRD-160009
Telif hakkı ve lisans
Telif hakkı © 2026 Yazar(lar). Açık erişimli bu makale, orijinal çalışmaya uygun şekilde atıfta bulunulması koşuluyla, herhangi bir ortamda veya formatta sınırsız kullanım, dağıtım ve çoğaltmaya izin veren Creative Commons Atıf Lisansı (CC BY) altında dağıtılmıştır.
